| General Information of Drug Metabolite (DM) (ID: DM005995) |
| DM Name |
21,22-HDoHE
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 3A4 (CYP3A4)
|
DME0001
|
| Unclear - Unclear |
SCH-417690
|
[1] |
|
Lauric acid omega-hydroxylase (CYP4A11)
|
DME0029
|
| Unclear - Unclear |
SC-411
|
[2] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| SCH-417690 |
DR1683
|
Phase 3 |
Human immunodeficiency virus infection |
|
|
| SC-411 |
DR0521
|
Phase 3 |
Alzheimer disease |
|
|
| References |
| 1 |
Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
|
| 2 |
CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease? Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):99-108.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
